Spotlight on brexpiprazole and its potential in the treatment of schizophrenia and as adjunctive therapy for the treatment of major depression

Antipsychotic agents, utilized for the treatment of a range of psychiatric disorders, differ substantially in terms of their pharmacology and adverse effect profiles. Incomplete and variable efficacy, differences in safety–tolerability, and highly heterogeneous response across individuals prompt dev...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruijnzeel, Dawn, Tandon, Rajiv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869657/
https://www.ncbi.nlm.nih.gov/pubmed/27274197
http://dx.doi.org/10.2147/DDDT.S85089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869657/
https://www.ncbi.nlm.nih.gov/pubmed/27274197
http://dx.doi.org/10.2147/DDDT.S85089

Ejemplares similares